The FDA plans to authorize Pfizer-BioNTech vaccine for children aged 12 to 15 years

As children get set to head into the sun, grass, and water, now is the perfect time to remind patients and parents about best practices, treatments, and preventive measures.

A new study investigates taking this treatment a step further, evaluating the effect of epicutaneous immunotherapy in toddlers with known peanut allergies.

An increase in outpatient visits that included an anxiety diagnosis was also met with a decrease in treatment visits, while there was no significant change in the overall use of medications in all time periods.

Following household COVID-19 transmissions for over 3 years, investigators found that 70.4% had a pediatric index case.